Skip to content

Pregnancy in Women With HIV Infection

Pregnancy in Women With HIV Infection: a Multicenter Cohort in Spain

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04350554
Enrollment
160
Registered
2020-04-17
Start date
2020-09-01
Completion date
2021-06-30
Last updated
2020-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections, Pregnancy Related

Keywords

HIV, Pregnancy, Adverse pregnancy outcomes

Brief summary

Women living with HIV face multiple challenges regarding pregnancy, encompassing not only their intention to procreate, but also difficulties during the course of pregnancy. Compared to HIV-negative controls, HIV-infected women have a higher risk of pregnancy complications such as preeclampsia, gestational diabetes, or preterm labor. In addition, the treatment of HIV among pregnant women entails specific difficulties, such as changes in bioavailability of antiretroviral drugs, or the concern about the association of certain antiretrovirals with adverse pregnancy outcomes. There is very little evidence about pregnancy among women living with HIV in Spain. Very few studies have been published, performed in single centers or in small cohorts with a limited number of patients. The Cohort of the Spanish AIDS Research Network (CoRIS) offers a unique setting to answer questions that are unlikely to be answered by a single study. The aims of this study are (i) to describe the incidence of pregnancies and their temporal trends from 2004 to 2019, (ii) o describe the clinical and epidemiological characteristics of women who become pregnant, (iii) to assess the diagnostic delay among women diagnosed with HIV infection after becoming pregnant, (iv) to investigate the clinical course during pregnancy and its predictive factors, (v) to describe the antiretroviral treatment administered to pregnant women, (vi) to describe clinical outcomes after pregnancy, (vii) to describe the outcome of the conception in terms of interrupted pregnancies, spontaneous abortions, term pregnancies, type of delivery (vaginal or caesarean section) and HIV infection of the newborn, and (vii) to evaluate attitudes towards pregnancy (ie. planned pregnancy) and social support among women who become pregnant during the year 2020. Study population will be women from the cohort of the Spanish AIDS Research Network (CoRIS) who have become pregnant in the period 2004-2010.

Interventions

OTHERPregnancy

To measure and characterize pregnancies and describe the clinical course during pregnancy

Sponsors

Red Temática de Investigación Cooperativa en Sida
CollaboratorUNKNOWN
Merck Sharp & Dohme LLC
CollaboratorINDUSTRY
Carlos III Health Institute
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum

Inclusion criteria

* HIV-positive women recruited in CoRIS * Became pregnant from January 2004 to November 2019 * or become pregnant during the year 2020 and agree to participate in a telephone survey

Design outcomes

Primary

MeasureTime frameDescription
Incidence of pregnanciesFrom 2004 to 2019
Epidemiological characteristics of women who become pregnant2004 to 2019Proportion of diagnostic delay among women diagnosed with HIV infection after becoming pregnant
Clinical course during pregnancy2004 to 2019Proportion of women with undetectable viral load at week 36 of pregnancy
Opportunistic infections during pregnancy2004 to 2019Incidence of opportunistic infections throughout pregnancy
Persistence of Antiretroviral treatment (ART) during pregnancy2004 to 2019Time from ART initition to treatment change during pregnancy
Antiretroviral treatment (ART) administered to pregnant women2004 to 2019Distribution of ART regimens administered to women at pregnancy
Follow-up after pregnancy2004 to 2019Rate of lost-to-follow-up during the first year after pregnancy termination
Clinical outcomes after pregnancy2004 to 2019Proportion of women with undetectable viral load 6 months after pregnancy termination
Outcome of the conception2004 to 2019Proportion of interrupted pregnancies, spontaneous abortions and term pregnancies
Term pregnancies2004 to 2019Proportion of term pregnancies
Type of delivery2004 to 2019Proportion of vaginal deliveries
HIV infection of the newborn2004 to 2019Proportion of newborns with HIV infections
Attitudes towards pregnancyPregnancies during the year 2020Proportion of unintended pregnancies (unplanned or unwanted at the time of conception)

Contacts

Primary ContactInma Jarrin, PhD
ijarrin@isciii.es0034918222863

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026